Skip to main content
TRMKTrustmark CorporationSell5.3·$46.27+0.52%
TRMK · Why this verdict

Why Trustmark (TRMK) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.3/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Trustmark Corporation has delivered three earnings beats in the last four quarters with strong momentum indicators including a golden cross and rising volume accumulation, but the stock is priced above analyst targets with negative asymmetry, limiting near-term upside relative to downside.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Supervisory oversight by both FRBA and MDBCF represents a dual regulatory burden that is explicitly cited as a concentration risk, which could constrain Trustmark's flexibility to pursue acquisitions, capital returns, or new business lines.

Stable
Bear case
Expectation
No new formal regulatory actions are announced and the bank maintains its current capital ratios above 10% tier-1 over the next 12 months, suggesting the dual oversight is routine rather than restrictive.

CounterDual regulatory supervision is common among community banks and does not inherently indicate elevated enforcement risk; the market may be over-pricing this concentration concern.

Trustmark has beaten EPS estimates in 3 of the last 4 quarters, with an average positive surprise of 5.35%, demonstrating consistent ability to outperform analyst expectations in a challenging regional banking environment.

Stable
Earnings
Expectation
Earnings beat rate remains above 75% over the next four quarters with average surprise staying above 4%, sustaining the recent track record of execution.

CounterRegional banks face persistent net interest margin compression from rate normalization; the beat streak could reverse quickly if deposit costs rise faster than loan repricing allows.

A golden cross pattern with RSI at 55 and rising on-balance volume confirms that institutional buying pressure has been building, placing Trustmark in a technical breakout setup supported by volume accumulation above all major moving averages.

Stable
Momentum breakdown
Expectation
Price sustains above the 200-day moving average for at least 6 of the next 9 months, with on-balance volume continuing its upward trend.

CounterAt only 2.5% below its 52-week high and already past the analyst price target, the breakout may be exhausted, making further gains dependent on a re-rating that is not currently supported by analyst consensus.

With the stock trading above the analyst consensus price target — reflected in a negative upside of -8.6% — the current price embeds expectations that exceed what professional analysts currently believe the business is worth.

Stable
Warnings
Expectation
Analyst price targets rise at least 10% above the current price of $45.17 within 12 months, providing renewed fundamental support for the current valuation.

CounterAnalyst targets lag price action in strong momentum stocks; institutional accumulation reflected in rising on-balance volume may indicate the market is ahead of published analyst models.

Per-dimension breakdown

Value

6.8/10data confidence 83%
ComponentSub-score
P/E8.6
P/S8.0
Fwd P/E9.1
PEG5.4
Analyst target3.0
  • Forward P/E: 11.3x
  • PEG: 1.41

Quality

5.1/10data confidence 100%
ComponentSub-score
ROE3.6
ROA0.8
Gross margin0.0
Op margin10.0
Net margin10.0
Moat4.8
Piotroski F6.7
  • Strong margins: 28%
  • No competitive moat

Growth

3.8/10data confidence 67%
ComponentSub-score
Rev growth3.9
EPS growth3.6

Momentum

6.5/10data confidence 100%
ComponentSub-score
RSI4.5
MACD9.2
OBV10.0
MA position9.0
Volume0.0
  • Overbought (RSI 70)
  • Volume accumulation (rising OBV)
  • Above 200-day MA

Sentiment

5.1/10data confidence 100%
ComponentSub-score
Analyst rating5.0
Price target5.4
erm sentiment5.0

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.0
  • No net insider activity — $0 (0.000% of mkt cap)

Peer rank

4.8/10data confidence 80%
ComponentSub-score
value rank7.2
quality rank4.8
growth rank2.2

Technical

3.9/10data confidence 100%
ComponentSub-score
bollinger0.8
support resistance0.9
52w position9.9

Risk (lower is worse)

5.5/10data confidence 100%
ComponentSub-score
short interest6.2
days to cover1.4
volatility7.5
implied vol5.6
max pain risk3.0
beta9.1
  • Above max pain $25
  • Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

6.1/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg5.2
dividend safety5.2
  • Strong earnings: 3B/0M
  • Dividend: 217.0%

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (6)
  • MOMENTUM:6.5>=5.5
  • INSIDER:OK
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:26d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-1.4=NEGATIVE
Warning (1)
  • 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-1.45
Upside
-10.8%
Downside
7.4%
Sizing output
AVOID

SetupUNKNOWN No clear chart pattern; technical signals are mixed

EdgeCATALYST Earnings in 26d with 3/4 beat streak

SuitabilityAGGRESSIVE MCap $2.7B<$5B

Investment implication

The F-path SELL output reflects an overall score of 5.3 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Value at 6.8) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-1.4=NEGATIVE) reinforce the read. Current asymmetry R:R is -1.45 — supplementary context, not the trigger for this path.

The strongest dimensions are Value at 6.8, Momentum at 6.5, and Catalyst at 6.1; the weakest are Growth at 3.8, Technical at 3.9, and Peer rank at 4.8. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -1.45 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Trustmark has beaten EPS estimates in 3 of the last 4 quarters, with an average positive surprise of 5.35%, demonstrating consistent ability to outperform analyst expectations in a challenging regional banking environment.

    Trip ifEPS surprise falls below 0% in at least 3 of the next 4 quarters, reversing the recent beat streak and signaling deteriorating earnings execution.

  • P2A golden cross pattern with RSI at 55 and rising on-balance volume confirms that institutional buying pressure has been building, placing Trustmark in a technical breakout setup supported by volume accumulation above all major moving averages.

    Trip ifPrice drops below the 200-day moving average and stays below it for more than 30 consecutive days, breaking the breakout setup.

  • P3Supervisory oversight by both FRBA and MDBCF represents a dual regulatory burden that is explicitly cited as a concentration risk, which could constrain Trustmark's flexibility to pursue acquisitions, capital returns, or new business lines.

    Trip ifThe share price drops below $38, more than 15% below the current $45.17, following a formal regulatory enforcement action against the bank.

  • P4With the stock trading above the analyst consensus price target — reflected in a negative upside of -8.6% — the current price embeds expectations that exceed what professional analysts currently believe the business is worth.

    Trip ifAnalyst consensus price target declines below $40.00, signaling that professional models are marking down intrinsic value rather than catching up to the current price.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks TRMK Why this verdict